- Home
- NVRI vs NEO Comparison
NVRI vs NEO Comparison
Compare NVRI & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVRI
- NEO
- Stock Information
- Founded
- NVRI 1853
- NEO 2001
- Country
- NVRI United States
- NEO United States
- Employees
- NVRI N/A
- NEO N/A
- Industry
- NVRI Diversified Commercial Services
- NEO Precision Instruments
- Sector
- NVRI Miscellaneous
- NEO Health Care
- Exchange
- NVRI Nasdaq
- NEO Nasdaq
- Market Cap
- NVRI 756.7M
- NEO 709.2M
- IPO Year
- NVRI N/A
- NEO 1999
- Fundamental
- Price
- NVRI $9.78
- NEO $6.21
- Analyst Decision
- NVRI Hold
- NEO Buy
- Analyst Count
- NVRI 1
- NEO 8
- Target Price
- NVRI $10.00
- NEO $12.00
- AVG Volume (30 Days)
- NVRI 806.7K
- NEO 3.1M
- Earning Date
- NVRI 08-05-2025
- NEO 07-29-2025
- Dividend Yield
- NVRI N/A
- NEO N/A
- EPS Growth
- NVRI N/A
- NEO N/A
- EPS
- NVRI N/A
- NEO N/A
- Revenue
- NVRI $2,242,873,000.00
- NEO $689,189,000.00
- Revenue This Year
- NVRI $0.02
- NEO $13.83
- Revenue Next Year
- NVRI $3.71
- NEO $11.35
- P/E Ratio
- NVRI N/A
- NEO N/A
- Revenue Growth
- NVRI N/A
- NEO 9.70
- 52 Week Low
- NVRI $4.72
- NEO $4.72
- 52 Week High
- NVRI $11.95
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- NVRI 61.61
- NEO 50.53
- Support Level
- NVRI $7.70
- NEO $5.37
- Resistance Level
- NVRI $9.04
- NEO $6.34
- Average True Range (ATR)
- NVRI 0.50
- NEO 0.39
- MACD
- NVRI 0.09
- NEO 0.13
- Stochastic Oscillator
- NVRI 83.67
- NEO 91.98
About NVRI Enviri Corporation
Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.